191 related articles for article (PubMed ID: 15709036)
1. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor.
Frampton AR; Goins WF; Cohen JB; von Einem J; Osterrieder N; O'Callaghan DJ; Glorioso JC
J Virol; 2005 Mar; 79(5):3169-73. PubMed ID: 15709036
[TBL] [Abstract][Full Text] [Related]
2. Equine herpesvirus infections in yearlings in South-East Queensland.
Diallo IS; Hewitson GR; de Jong A; Kelly MA; Wright DJ; Corney BG; Rodwell BJ
Arch Virol; 2008; 153(9):1643-9. PubMed ID: 18677574
[TBL] [Abstract][Full Text] [Related]
3. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.
Azab W; Osterrieder N
J Virol; 2012 Feb; 86(4):2031-44. PubMed ID: 22171258
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission.
Spiesschaert B; Osterrieder N; Azab W
Viruses; 2015 Feb; 7(2):522-42. PubMed ID: 25654240
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
7. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.
Azab W; Zajic L; Osterrieder N
Vet Res; 2012 Aug; 43(1):61. PubMed ID: 22909178
[TBL] [Abstract][Full Text] [Related]
8. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.
Van de Walle GR; Peters ST; VanderVen BC; O'Callaghan DJ; Osterrieder N
J Virol; 2008 Dec; 82(23):11859-68. PubMed ID: 18815313
[TBL] [Abstract][Full Text] [Related]
9. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.
Frampton AR; Stolz DB; Uchida H; Goins WF; Cohen JB; Glorioso JC
J Virol; 2007 Oct; 81(20):10879-89. PubMed ID: 17670830
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
[TBL] [Abstract][Full Text] [Related]
11. Equine alphaherpesviruses (EHV-1 and EHV-4) differ in their efficiency to infect mononuclear cells during early steps of infection in nasal mucosal explants.
Vandekerckhove AP; Glorieux S; Gryspeerdt AC; Steukers L; Van Doorsselaere J; Osterrieder N; Van de Walle GR; Nauwynck HJ
Vet Microbiol; 2011 Aug; 152(1-2):21-8. PubMed ID: 21536394
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
[TBL] [Abstract][Full Text] [Related]
13. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.
Geraghty RJ; Fridberg A; Krummenacher C; Cohen GH; Eisenberg RJ; Spear PG
Virology; 2001 Jul; 285(2):366-75. PubMed ID: 11437670
[TBL] [Abstract][Full Text] [Related]
14. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
15. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
16. Equine herpesvirus-1: what are we still missing?
Hussey GS
Vet J; 2012 Aug; 193(2):309-10. PubMed ID: 22738739
[No Abstract] [Full Text] [Related]
17. Cellular expression of alphaherpesvirus gD interferes with entry of homologous and heterologous alphaherpesviruses by blocking access to a shared gD receptor.
Geraghty RJ; Jogger CR; Spear PG
Virology; 2000 Mar; 268(1):147-58. PubMed ID: 10683337
[TBL] [Abstract][Full Text] [Related]
18. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
19. Equine herpesvirus-1: a neurotropic alphaherpesvirus.
Slater JD; Borchers K; Field HJ
Vet Rec; 1994 Sep; 135(10):239-40. PubMed ID: 7801451
[No Abstract] [Full Text] [Related]
20. Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D.
Sasaki M; Hasebe R; Makino Y; Suzuki T; Fukushi H; Okamoto M; Matsuda K; Taniyama H; Sawa H; Kimura T
Genes Cells; 2011 Apr; 16(4):343-57. PubMed ID: 21306483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
